Skip to main content
SpringerLink
Log in

Seminar / Gastroenterologie

Statine bei Erkrankungen der Leber: Hopp oder top?

Statin use in patients with liver disease - overview and results from a retrospektive observational study

  • FB_Seminar
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Mod. n. Markova AA. Eur J Gastroenterol Hepatol. 2021;32:223-9

Author information

Authors and Affiliations

  1. Klinik für Gastroenterologie und Hepatologie, Universitäts­klinikum Essen, Essen, Deutschland

    Antoaneta Markova

  2. Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Deutschland

    Heiner Wedemeyer

Authors
  1. Antoaneta Markova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heiner Wedemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antoaneta Markova.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markova, A., Wedemeyer, H. Statine bei Erkrankungen der Leber: Hopp oder top?. MMW - Fortschritte der Medizin 163, 74–77 (2021). https://doi.org/10.1007/s15006-021-9604-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-021-9604-5

Keywords:

Search

Navigation